Company Directory

AllRight.com is an online English learning platform for children. The platform uses songs, games, and body language to make learning fun.

Alpaca builds a commission-free, developer-first API for stock trading for users to trade with algorithms, connect with apps, and build services.

AlphaFlow is a tech-driven investment manager, providing professionally managed portfolios of real estate loans to institutional investors. They partner with non-bank real estate lenders around the country who provide 6-12 month bridge loans on single-family and small multifamily properties, to buy their loans and help them grow their businesses.

Alt is an alternative asset platform aiming at increasing the transparency and liquidity of alternative assets. Its users can invest in sports cards just like in stocks.

Alto Solutions is a self-directed IRA with allows individuals to invest in alternative assets like real estate, cryptocurrency, and startups.

AltPep Corporation is a biomedical startup with a novel approach for diagnosing and treating amyloid diseases and CNS disorders such as Alzheimer’s Disease.

AltruBio is a biopharmaceutical company developing immune-modulators to target diseases of the immune system.

alwaysAI is a computer vision platform for developers. The platform facilitates ​​building, deploying, and managing deep learning computer vision applications on IoT devices.

ALX Oncology is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. Our lead candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated proprietary Fc domain. We have developed a new approach to CD47 blockade that is designed to maximize clinical activity and minimize toxicities.

Amenify is a concierge platform that offers services to properties and residents with technology that powers convenient apartment living.

Amwell is a telehealth company whose mission is to connect and enable providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care with their all-inclusive telehealth platform.

Amesite is a technology company that uses artificial intelligence software and a cloud-based platform to deliver branded educational content serving K-12, higher education, and even profession learning.

Andium is an Industrial Internet of Things technology company. Its end-to-end platform offers industries increased flexibility, reliability, and scalability in monitoring and controlling their operations, regardless of cloud connectivity.

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Their platform technology addresses well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway.

Anthem IQ offers a technology platform for commercial real estate brokers to interact with their clients, streamline processes, and manage their entire CRE workflow from search to signed lease.

Anvilogic is a cybersecurity company. Its AI platform automates the bulk of SOC detection and response workflow.

AnyRoad is an ERM platform that allows companies to access all experiential data and insights including analytics, customer insights, and data management in order to build better brand marketing at scale.

APERIO Systems is on a mission to build the best data integrity product to help you make informed quality-data-driven decisions using their industrial critical control systems with true state awareness.

Appia Bio is a biotechnology company focused on discovering and developing engineered allogeneic cell therapies.The company uses hematopoietic stem cells (HSCs) to treat and cure cancer.

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.